KO Cancer Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 6807.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. FITZPATRICK, as printed in the Congressional Record (Vol. 169, No. 206, December 14, 2023, Page H6987):
  Article I, Section 8, Clause 18 The single subject of this legislation is: Increases cancer funding by 25% to the National Cancer Institute (NCI) for FY24-FY28 and asks for a study and report to Congress on the cancer drug shortage.
  Source: Congress.gov, Congressional Record December 14, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  232 characters

  Congress.gov bill record

  H.R. 6807, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/6807

  Record last updated by Congress.gov

  December 4, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  73a3334c9440bd291ee7ab0e11f9d37e5d5dd361e24b9a87a994db4b9ec12427

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 4, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 6807, last updated December 4, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.